MedscapeUnivadisEnglish EditionMedscapeUnivadisXPlease confirm that you would like to log out of Medscape.If you log out, you will be required to enter your username and password the next time you visit.>>>The growing popularity using anesthetic nitrous oxide recreationally is linked to an upsurge in young people presenting to the hospital with neurologic complaints.In a case series, investigators at Zuyderland Medisch Centrum, Heerlen, the Netherlands, report an increase in young patients presenting with polyneuropathy or subacute spinal cord degeneration — common side effects of...…MedscapeUnivadisEnglish EditionMedscapeUnivadisXPlease confirm that you would like to log out of Medscape.If you log out, you will be required to enter your username and password the next time you visit.>>>The growing popularity using anesthetic nitrous oxide recreationally is linked to an upsurge in young people presenting to the hospital with neurologic complaints.In a case series, investigators at Zuyderland Medisch Centrum, Heerlen, the Netherlands, report an increase in young patients presenting with polyneuropathy or subacute spinal cord degeneration — common side effects of...WW…

MedscapeUnivadisEnglish EditionMedscapeUnivadisXPlease confirm that you would like to log out of Medscape.If you log out, you will be required to enter your username and password the next time you visit.>>>Plasma exchange (PE) with albumin replacement may be effective for slowing down symptoms of Alzheimer's disease (AD), new research suggests.Results from the phase 2b/3 AMBAR study showed that the treatment, which aims to remove amyloid beta (Aβ) from plasma, was associated with a 60% decrease in functional and cognitive decline in patients with moderate AD.Dr Antonio PáezThe...…MedscapeUnivadisEnglish EditionMedscapeUnivadisXPlease confirm that you would like to log out of Medscape.If you log out, you will be required to enter your username and password the next time you visit.>>>Plasma exchange (PE) with albumin replacement may be effective for slowing down symptoms of Alzheimer's disease (AD), new research suggests.Results from the phase 2b/3 AMBAR study showed that the treatment, which aims to remove amyloid beta (Aβ) from plasma, was associated with a 60% decrease in functional and cognitive decline in patients with moderate AD.Dr Antonio PáezThe...WW…